CAS number index
Every CAS Registry Number in our catalogue, sorted numerically. Paste a CAS No. into the search bar to jump straight to the product.
| CAS No. | Substance | Grades |
|---|---|---|
| 391860-73-4 | Efavirenz USP Related Compound C | 1 |
| 391901-45-4 | (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol | 1 |
| 392711-19-2 | Rapamycin-D3 | 1 |
| 393078-37-0 | 2,3-Dichloro-6-nitrobenzyl Alcohol | 1 |
| 393105-53-8 | Tiplaxtinin, ≥98% | 1 |
| 393825-04-2 | 2,3-Dehydro Simvastatin Acid (Sodium Salt) | 1 |
| 394222-30-1 | Methyl 2-(4-(4-Hydroxybutanoyl)phenyl)-2-methylpropanoate | 1 |
| 394730-60-0 | Boceprevir | 1 |
| 394735-37-6 | (1R,2S,5S)-3-((S)-2-((tert-Butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic Acid | 1 |
| 395067-42-2 | Midazolam D5 | 1 |
| 395683-14-4 | Imrecoxib | 1 |
| 396684-42-7 | Capecitabine Impurity 9 | 1 |
| 396731-20-7 | Ent-Avibactam Sodium | 1 |
| 397246-12-7 | R 2 tert butyloxycarbonylamino pentane 1 5 diol | 1 |
| 397864-40-3 | Fluticasone Thioacid-17-furoate | 1 |
| 397864-44-7 | Fluticasone Furoate | 1 |
| 397864-56-1 | Fluticasone 11-Keto Impurity | 1 |
| 397864-58-3 | S-Methyl Fluticasone Furoate | 1 |
| 397864-63-0 | Fluticasone Furoate EP Impurity A | 1 |
| 398156-38-2 | 2,2-Difluoro-1,3-benzodioxole-5-acetic Acid | 1 |
| 398454-97-2 | Fluticasone Furoate EP Impurity E | 1 |
| 398454-98-3 | Fluticasone Furoate 1,2 dihydro Impurity | 1 |
| 398489-26-4 | 1-Boc-3-azetidinone | 1 |
| 399017-10-8 | Ethyl 2-(4-Hydroxyphenyl)-4-methylthiazole-5-carboxylate Hydrochloride | 1 |
| 400024-08-0 | Amlodipine Related Compound (E-Isomer) | 1 |
| 400024-12-6 | Amlodipine EP Impurity E Maleate | 1 |
| 400038-68-8 | 2-Keto Zolpidem | 1 |
| 400063-10-7 | Milrinone IMpurity 2 | 1 |
| 400602-35-9 | Amlodipine Aspartic Acid Impurity | 1 |
| 400602-36-0 | Amlodipine Maleic Acid Amide Impurity | 1 |
| 400777-11-9 | Zolpidem Carbaldehyde | 1 |
| 400827-46-5 | Ceftaroline fosamil acetate | 1 |
| 400827-68-1 | (6R,7R)-Benzhydryl 8-oxo-7-(2-phenylacetamido)-3-((4-(pyridin-4-yl)thiazol-2-yl)thio)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | 1 |
| 400882-07-7 | Cyflumetofen | 1 |
| 400898-77-3 | trans-(4-Methylaminocyclohexyl)methanol | 1 |
| 401564-30-5 | (2R,4S)-Tert-Butyl 4-hydroxy-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate | 1 |
| 401564-34-9 | (2S,4S)-tert-Butyl 4-hydroxy-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate | 1 |
| 401564-36-1 | (2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester | 1 |
| 401566-79-8 | 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine | 1 |
| 401566-80-1 | tert-Butyl (2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]-2-[(1,3-thiazolidin-3-yl)carbonyl]pyrrolidine-1-carboxylate | 1 |
| 401788-98-5 | 1-Butyl-3-methylimidazolium methyl sulphate, ≥95% | 2 |
| 401788-99-6 | 1-Butyl-4-methylpyridinium hexafluorophosphate, ≥97% | 1 |
| 401915-53-5 | Fmoc-D-Homoarg(Pbf)-OH | 1 |
| 402470-91-1 | Zolpidem EP Impurity F | 1 |
| 402615-91-2 | Fingolimod phosphate | 1 |
| 402725-23-9 | 1-((2S,3S,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one | 1 |
| 402746-56-9 | Clopidogrel Impurity B | 1 |
| 402824-96-8 | Hydrochlorothiazide EP Impurity C | 1 |
| 402846-78-0 | 1-Butyl-2,3-dimethylimidazolium tetrafluoroborate, 97% | 2 |
| 402848-76-4 | 2-Acetoxy-N-(2-thiazolyl)benzamide | 1 |
| 402849-25-6 | Indometacin EP Impurity J | 1 |
| 402849-26-7 | Indometacin - Impurity G | 1 |
| 402849-27-8 | Indometacin EP Impurity F | 1 |
| 402855-03-2 | 4-N-(3-Chloro-4-fluorophenyl)-7-[(3R)-oxolan-3-yl]oxyquinazoline-4,6-diamine | 1 |
| 402855-07-6 | (R)-N-(3-Chloro-4-fluorophenyl)-6-nitro-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-amine | 1 |
| 402955-37-7 | Ertapenem Dimer Impurity | 1 |
| 402955-38-8 | Ertapenem Dimer Ester Impurity | 1 |
| 402957-28-2 | Telaprevir | 1 |
| 403656-89-3 | 17-Keto Fulvestrant | 1 |
| 403842-84-2 | 1-Methyl-3-octylimidazolium trifluoromethanesulfonate, 97.0% | 1 |
| 403848-01-1 | Dorzolamide Desaminosulfonyl HCl | 1 |
| 403848-09-9 | N-Acetyl Dorzolamide | 1 |
| 404034-55-5 | N-Desethyl Brinzolamide | 1 |
| 404830-45-1 | 15-Keto Travoprost | 1 |
| 404839-11-8 | Clavulanate Potassium EP Impurity D | 1 |
| 404844-02-6 | Imatinib EP Impurity C | 1 |
| 404844-11-7 | N-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-chloromethyl Benzamide | 1 |
| 404874-93-7 | (R)-1-(4-Fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5-dione | 1 |
| 404874-94-8 | (4R)-3-[(5S)-5-(4-Fluorophenyl)-5-Hydroxypentanoyl]-4-Phenyl-1,3-Oxazolidin-2-One | 1 |
| 404950-80-7 | Panobinostat | 1 |
| 404958-08-3 | tert-Butyl 6-Chloro-(R)-hydroxy-3-oxohexanoate | 1 |
| 404958-68-5 | tert-Butyl (3S,4R)-6-Chloro-3,5-dihydroxyhexanoate | 1 |
| 404958-69-6 | tert-Butyl (3R,5R)-6-Chloro-5-hydroxy-3-oxohexanoate | 1 |
| 405165-61-9 | Besifloxacin Hydrochloride | 1 |
| 405230-78-6 | 3-Chloro-2,6-difluoropyridin-4-amine | 1 |
| 405872-78-8 | (Z)-Ethyl 2-chloro-2-(2-(3-methoxyphenyl)hydrazono)acetate | 1 |
| 405897-14-5 | Dimethyl2,3-dihydroxysuccinate | 1 |
| 405906-96-9 | 5-Oxo-6E, 8E-Octadecadienoic Acid | 1 |
| 406233-31-6 | 4-Fluoro-3-nitrobenzenesulfonamide | 1 |
| 406484-56-8 | 2-Chloro-4-(piperidin-1-ylmethyl)pyridine oxalate | 1 |
| 406938-39-4 | (1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid | 1 |
| 407577-53-1 | Fulvestrant EP Impurity A | 1 |
| 407577-54-2 | (4R,6R)-6-Hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester | 1 |
| 407582-47-2 | Febuxostat 67M-2 | 1 |
| 407582-48-3 | Desisobutyl Febuxostat | 1 |
| 407582-49-4 | 2-[4-(2-Carboxypropoxy)-3-cyanophenyl]-4-methyl-5-thiazolecarboxylic Acid | 1 |
| 408309-07-9 | Alverine EP Impurity E | 1 |
| 408321-08-4 | 7-O-Desmethyl Temsirolimus | 1 |
| 408496-50-4 | Rapamycin, 7-O-demethyl-42-O-(2-hydroxyethyl)-, (7ξ) | 1 |
| 408508-13-4 | Dasatinib Impurity 52 | 1 |
| 408531-05-5 | N-Acetyl Hypoxanthine | 1 |
| 409071-16-5 | Lithium difluoro(oxalato)borate, 95% | 1 |
| 409346-73-2 | 6-Fluorochromane-2-carbaldehyde | 1 |
| 410522-18-8 | 1-Butyl-3-methylimidazolium tosylate, ≥97% | 1 |
| 410528-02-8 | Palovarotene | 1 |
| 411221-53-9 | Citalopram EP Impurity B | 1 |
| 411235-57-9 | Cyclopropylboronic acid, 96% | 1 |
| 412009-61-1 | 1-Ethyl-3-methylimidazolium hydrogen sulphate, 95% | 2 |
| 412308-26-0 | Biotin EP Impurity C (2HCl) | 1 |
| 412940-03-5 | 4-((5-Hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl)methoxy)-4-oxobutanoic acid | 1 |
| 413589-34-1 | 3-Chloro-4-fluorophenylmagnesium bromide, 0.5 M in THF | 1 |
| 413624-71-2 | 2,2,14,14-Tetramethyl-8-oxopentadecanedioic acid | 1 |
| 414858-02-9 | Plerixafor Impurity 2 | 1 |
| 414881-11-1 | 1-Ethyl-4-(pyridin-3-ylmethyl)piperazine | 1 |
| 415724-02-6 | Gemfibrozil EP Impurity H | 1 |
| 415725-35-8 | Biotin EP Impurity D | 1 |
| 415726-68-0 | Imiquimod impurity | 1 |
| 415903-37-6 | Galliprant | 1 |
| 415908-90-6 | 4-[(2,6-Dimethyl-3-nitro-4-pyridinyl)amino]benzeneethanol | 1 |
| 415973-05-6 | Rivastigmine EP Impurity D | 1 |
| 416845-90-4 | DL-Homocysteine-d4 | 1 |
| 417714-14-8 | 4-(4-(3-Cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide | 1 |
| 417716-92-8 | Lenvatinib | 1 |
| 417717-04-5 | O-Demethyl Lenvatinib | 1 |
| 417717-21-6 | Desamino Hydroxy Lenvatinib | 1 |
| 417719-45-0 | N-Methyl Lenvatinib | 1 |
| 417719-46-1 | Lenvatinib N-Ethyl Impurity | 1 |
| 417719-51-8 | Descyclopropyl Lenvatinib Impurity | 1 |
| 417721-15-4 | 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carbonitrile | 1 |
| 417721-34-7 | 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylic acid | 1 |
| 417721-36-9 | 4-Chloro-7-methoxy-6-quinolinecarboxamide | 1 |
| 417722-93-1 | Lenvatinib Phenoxy Quinoline Impurity | 1 |
| 417722-95-3 | Phenyloxy Descyclopropylamino Lenvatinib | 1 |
| 417724-81-3 | Lenvatinib Quinoline Metabolite | 1 |
| 419534-31-9 | 9-cis Acitretin | 1 |
| 419534-37-5 | 2-Cyano-N-[2-(trifluoromethyl)phenyl]acetamide | 1 |
| 419574-04-2 | Aprepitant M3 Metabolite (1R, 5S, 6R)-Isomer | 1 |
| 419574-33-7 | (5R,6R)-6-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-5-(4-fluorophenyl)-3-morpholinone | 1 |
| 420846-72-6 | OPD-3A System Suitability Standard | 1 |
| 421552-12-7 | 2-Cyano-5-Fluorobenzyl Bromide | 1 |
| 421552-35-4 | (4R,4AS,7aR,12bS)-3-(Cyclopropylmethyl)-4a-hydroxy-7-oxo-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-9-carboxamide | 1 |
| 422556-08-9 | Pyroxsulam | 1 |
| 423165-13-3 | 8-Azabicyclo[3.2.1]octane, 3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-(phenylmethyl)-, (3-exo) | 1 |
| 425365-64-6 | Roxithromycin Impurity - G | 1 |
| 425365-65-7 | Roxithromycin EP Impurity H | 1 |
| 425365-66-8 | Roxithromycin EP Impurity I | 1 |
| 425394-92-9 | (1S,4S)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol | 1 |
| 425407-43-8 | Prototribestin | 1 |
| 425408-16-8 | Atorvastatin-Amlodipine Adduct | 1 |
| 426267-22-3 | Sugammadex Impurity 18 | 1 |
| 426268-06-6 | Nvp-abe171 | 1 |
| 428854-24-4 | Riociguat Triamino Impurity | 1 |
| 429658-95-7 | Dabigatran Etexilate Mesilate Impurity B | 1 |
| 429659-01-8 | Dabigatran Impurity 8 | 1 |
| 431041-83-7 | Rink Amide MBHA resin (100-200 mesh), 1% DVB | 1 |
| 431070-70-1 | 3-O-Demethyl Ivermectin B1a | 1 |
| 432543-89-0 | Desloratidine EP Impurity B Hydrochloride | 1 |
| 432545-63-6 | Methotrexate-d3 | 1 |
| 433289-83-9 | Atorvastatin EP Impurity A (Calcium Salt) | 1 |
| 433289-84-0 | Atorvastatin EP Impurity A | 1 |
| 433337-11-2 | 1-Benzyl-3-methylimidazolium hexafluorophosphate, ≥97.0% | 1 |
| 433936-13-1 | 1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol | 1 |
| 435273-75-9 | O-Benzyl Indacaterol | 1 |
| 435293-66-6 | 4'-Hydroxy Atomoxetine | 1 |
| 437611-17-1 | [Abu]5-Cyclosporin | 1 |
| 437713-06-9 | Atazanavir Hydrazine Analog | 1 |
| 437717-43-6 | Vardenafil EP Impurity B | 1 |
| 437723-96-1 | Bupropion R Isomer | 1 |
| 438045-89-7 | Rebaudioside F | 1 |
| 438050-08-9 | (R)-1-Boc-3-ethyl-piperazine, 98% | 1 |
| 438056-69-0 | 4-(4-Aminophenyl)-3-morpholinone | 1 |
| 438226-82-5 | (R)-1-(3-((1-Methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indol-1-yl)ethan-1-one | 1 |
| 438226-83-6 | Eletriptan Dimer Impurity | 1 |
| 438244-27-0 | Norethindrone Acetate EP Impurity G | 1 |
| 438244-33-8 | Norethindrone 6-alpha-Hydroxy Impurity | 1 |
| 438450-43-2 | 2-(3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-6-chloro-3,8-dimethylquinazolin-4(3H)-one | 1 |
| 438624-68-1 | Ezetimibe-13C6 | 1 |
| 439086-76-7 | (R)-2-(2-((3,3-Dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetic acid | 1 |
| 439087-18-0 | Elobixibat | 1 |
| 439087-68-0 | Elobixibat S-Isomer | 1 |
| 439088-16-1 | 3,3-Dibutyl-8-hydroxy-7-(methylthio)-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepine 1,1-dioxide | 1 |
| 439088-19-4 | Elobixibat Methyl Ester Impurity | 1 |
| 439088-54-7 | Elobixibat Tetra Butyl Impurity | 1 |
| 439134-46-0 | 1-(3,4-Dichlorophenyl)-1,2-dihydronaphthalene | 1 |
| 439239-90-4 | Lasmiditan | 1 |
| 439239-92-6 | Lasmiditan Hemisuccinate | 1 |
| 439612-08-5 | Vibegron N-Boc Amino Alcohol Impurity | 1 |
| 439858-21-6 | (S)-(+)-1-[(4-Chlorophenyl)phenylmethyl]piperazine | 1 |
| 439937-61-8 | 4-(3-Butyl-1-imidazolio)-1-butanesulphonate, ≥98% | 1 |
| 440121-09-5 | Citalopram Carboxylic Acid Impurity | 1 |
| 440124-53-8 | 4 4 Dimethylamino 1 4 fluorophenyl 1 hydroxybutyl 3 hydroxymethyl benzoic acid | 1 |
| 440124-96-9 | Efavirenz USP Related Compound B | 1 |
| 440358-84-9 | Amlodipine Mesilate Monohydrate | 1 |
| 441019-91-6 | Acebutolol EP Impurity I | 1 |
| 441045-17-6 | Eribulin mesylate | 1 |
| 441796-13-0 | N-Despropyl-N-Ethyl Macitentan | 1 |
| 441797-83-7 | N-[5-(4-Bromophenyl)-6-chloro-4-pyrimidinyl]-N'-ethylsulfamide | 1 |
| 441798-25-0 | N-Despropyl-N-Methyl Macitentan | 1 |
| 441798-33-0 | Macitentan | 1 |
| 441798-36-3 | Macitentan Impurity C | 1 |
| 442129-37-5 | 6-Amino-2-chloro-3-picoline | 1 |
| 442201-24-3 | Remogliflozin Etabonate | 1 |
| 442526-91-2 | Ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate | 1 |
| 442851-50-5 | Atorvastatin Dehydro Lactone | 1 |
| 442863-80-1 | (R)-Cetirizine N-Oxide | 1 |
| 443093-86-5 | N-((2'-Cyano-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valine | 1 |
| 443642-59-9 | 4-Chloro-1H-Pyrrolo[2,3-D]Pyrimidine Sodium Salt | 1 |
| 443913-73-3 | Vandetanib | 1 |
| 443982-76-1 | Tapinarof Phosphate Impurity | 1 |
| 444289-17-2 | Pomalidomide Impurity 18 | 1 |
| 444315-16-6 | PSS-[3-(2-Aminoethyl)amino]propyl-Heptaisobutyl substituted | 1 |
| 444335-16-4 | (5R)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)-2-oxazolidinone | 1 |
| 444576-08-3 | Bortezomib D-mannitol | 1 |
| 444577-70-2 | Atorvastatin Diketo Amide Desfluoro Impurity | 1 |
| 444728-13-6 | Clopidogrel EP Impurity E | 1 |
| 444728-15-8 | (R)-Clopidogrel EP Impurity E | 1 |
| 444731-52-6 | Pazopanib | 1 |
| 444731-72-0 | 6-Amino-2,3-dimethyl-2H-indazole | 1 |
| 444731-73-1 | 2,3-Dimethyl-6-Nitro-2H-Indazole | 1 |
| 444731-74-2 | Pazopanib Pyrimidine impurity | 1 |
| 444731-75-3 | Pazopanib Impurity A | 1 |
| 444904-63-6 | 2-Amino-5,6-Dichloro-3,4-Dihydroquinazoline | 1 |
| 445473-58-5 | 1-Butyl-3-methylimidazolium octyl sulphate, ≥95% (HPLC) | 1 |
| 446254-47-3 | Amifampridine Phosphate | 1 |
| 446292-04-2 | 4-(4-Nitrophenyl)morpholin-3-one | 1 |
| 446292-07-5 | Rivaroxaban Phthalimido Descarbonyl Impurity | 1 |
| 446292-08-6 | Rivaroxaban EP Impurity G | 1 |
| 446292-10-0 | Rivaroxaban Aminomethyl Impurity | 1 |
| 446299-88-3 | Ozenoxacin Quinoline pyridine Ester Impurity | 1 |
| 446299-90-7 | Ozenoxacin ETHYL Ester Impurity | 1 |
| 447399-55-5 | Pyroxasulfone | 1 |
| 447460-43-7 | 2,6-Difluorobenzenesulfonyl fluoride | 1 |
| 448184-46-1 | N-Desethyl Vardenafil | 1 |
| 448184-48-3 | Vardenafil N-Oxide | 1 |
| 448184-56-3 | Vardenafil Impurity 4 | 1 |
| 448184-58-5 | Vardenafil Oxopiperazine (Impurity) | 1 |
| 448245-52-1 | 1-Butyl-3-methylimidazolium dicyanamide, ≥97% (HPLC) | 1 |
| 448904-47-0 | O-Des Methyl Venlafaxine Succinate | 1 |
| 448950-89-8 | Alprazolam EP Impurity G | 1 |
| 449742-44-3 | Turpinionoside D | 1 |
| 450360-74-4 | Badge-2bpa | 1 |
| 452092-31-8 | Moxifloxacin Difluoro Hydroxy Ethyl Ester | 1 |
| 452105-33-8 | Sunitinib Carboxylic Acid Impurity | 1 |
| 452339-71-8 | tert-Butyl 2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxoethylcarbamate | 1 |
| 452339-73-0 | 2-Oxazolidinone, 5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-, (5R) | 1 |
| 452340-96-4 | 5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one | 1 |
| 452342-06-2 | Vilanterol Impurity 9 | 1 |
| 452342-07-3 | Vilanterol Impurity 10 | 1 |
| 454221-04-6 | Tapentadol EP Impurity A | 1 |
| 454479-37-9 | Posaconazole Impurity 114 | 1 |
| 454646-55-0 | N-Cyano-N′-[4-(4-morpholinyl)phenyl]guanidine | 1 |
| 454713-13-4 | (R)-tert-Butyl 1-benzylpiperidin-3-ylcarbamate | 1 |
| 455270-59-4 | 1-Hexyl-2,3-dimethyl imidazolium chloride, 98% | 1 |
| 457071-73-7 | Buprenorphine Related Compound A CII(Secondary Standards traceble to USP) | 1 |
| 457614-32-3 | Dinotefuran DN | 1 |
| 457639-26-8 | 2,5-Dimethyl Celecoxib | 1 |
| 458532-88-2 | 3-Fluoro-4-pyridineboronic acid pinacol ester, 98% | 1 |
| 458535-34-7 | Piperazine-1,4-diylbis(cyclopropylmethanone) | 1 |
| 459789-97-0 | (3α,5β,6α)-6-Ethyl-3-hydroxy-7-oxo-cholan-24-oic Acid Ethyl Ester | 1 |
| 459789-98-1 | Ethyl | 1 |